P. Mbouyap

Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2016 .

Epidemiology of Malaria in three Geo-Ecological Zones along the Chad-Cameroon Pipeline

R. Somo, P. Mbouyap, Eva Songue, 2013 .

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

M. Peeters, E. Delaporte, S. Eymard-Duvernay, 2017, The lancet. HIV.

Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP.

E. Delaporte, A. Galy, H. Abessolo, 2018, Patient education and counseling.